Idorsia Ltd

Status: Publicly traded

Direct answer

Idorsia Ltd is publicly traded on SIX under the ticker IDIA.SW.

Idorsia Ltd is a biopharmaceutical company based in Switzerland, dedicated to the discovery, development, and commercialization of innovative medicines that address significant unmet medical needs. The company maintains a diverse clinical development pipeline, with therapeutic focuses spanning central nervous system (CNS), cardiovascular, and immunological disorders, as well as various orphan diseases. Idorsia...

Can you invest in Idorsia Ltd?

Yes. Idorsia Ltd is publicly traded on SIX under the ticker IDIA.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Idorsia Ltd

Detailed equity research is provided by MarketSnap.